Two Sigma Advisers’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-397,322
Closed -$5.64M 21
2025
Q4
$5.64M Buy
+397,322
New +$7.52M 0.01% 753
2023
Q3
Sell
-7,600
Closed -$605K 2366
2023
Q2
$605K Sell
7,600
-23,600
-76% -$1.71M ﹤0.01% 1741
2023
Q1
$2.25M Buy
31,200
+2,500
+9% +$195K 0.01% 1213
2022
Q4
$2.36M Buy
+28,700
New +$2.37M 0.01% 1145
2022
Q2
Sell
-14,200
Closed -$931K 2623
2022
Q1
$931K Buy
+14,200
New +$825K ﹤0.01% 1675
2021
Q2
Sell
-4,400
Closed -$251K 2422
2021
Q1
$251K Sell
4,400
-8,400
-66% -$455K ﹤0.01% 2284
2020
Q4
$643K Buy
+12,800
New +$510K ﹤0.01% 1767
2014
Q1
Sell
-14,655
Closed -$694K 2219
2013
Q4
$694K Buy
+14,655
New +$637K 0.01% 1373
2013
Q3
Sell
-9,796
Closed -$324K 2056
2013
Q2
$324K Buy
+9,796
New +$318K ﹤0.01% 1662

Other funds holding ACHC

Two Sigma Advisers's ACHC Position: Q1 2026 in Review

Two Sigma Advisers sold out of Acadia Healthcare (ACHC) in Q1 2026, closing a stake of 397,322 shares — an estimated $5.64M sold.

Two Sigma Advisers first reported a position in ACHC in Q2 2013 and held it in 9 quarters. The position peaked at $5.64M in Q4 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Two Sigma Advisers reported no remaining Acadia Healthcare position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 397,322 Acadia Healthcare shares in Q1 2026, an estimated $5.64M.
  • Two Sigma Advisers first reported a position in Acadia Healthcare in Q2 2013 and held it in 9 quarters.
  • Two Sigma Advisers's Acadia Healthcare position peaked at $5.64M in Q4 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.